These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 18021708
21. G80A Single Nucleotide Polymorphism in Reduced Folate Carrier-1 Gene in a Mexican Population and its Impact on Survival in Patients with Acute Lymphoblastic Leukemia. Candelaria M, Ojeda J, Gutiérrez-Hernández O, Taja-Chayeb L, Vidal-Millán S, Dueñas-González A. Rev Invest Clin; 2016; 68(3):154-62. PubMed ID: 27409003 [Abstract] [Full Text] [Related]
22. Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status. Stocco G, Crews KR, Evans WE. Expert Opin Drug Saf; 2010 Jan; 9(1):23-37. PubMed ID: 20021291 [Abstract] [Full Text] [Related]
26. Heterozygosity at the TPMT gene locus, augmented by mutated MTHFR gene, predisposes to 6-MP related toxicities in childhood ALL patients. Karas-Kuzelicki N, Jazbec J, Milek M, Mlinaric-Rascan I. Leukemia; 2009 May; 23(5):971-4. PubMed ID: 18987660 [No Abstract] [Full Text] [Related]
28. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia. Stanulla M, Schaeffeler E, Flohr T, Cario G, Schrauder A, Zimmermann M, Welte K, Ludwig WD, Bartram CR, Zanger UM, Eichelbaum M, Schrappe M, Schwab M. JAMA; 2005 Mar 23; 293(12):1485-9. PubMed ID: 15784872 [Abstract] [Full Text] [Related]
29. High dose methotrexate treatment in childhood ALL: pilot study on the impact of the MTHFR 677C>T and 1298A>C polymorphisms on MTX-related toxicity. Haase R, Elsner K, Merkel N, Stiefel M, Mauz-Körholz C, Kramm CM, Körholz D. Klin Padiatr; 2012 Apr 23; 224(3):156-9. PubMed ID: 22513795 [Abstract] [Full Text] [Related]
31. Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia. Aplenc R, Lange B. Br J Haematol; 2004 May 23; 125(4):421-34. PubMed ID: 15142113 [Abstract] [Full Text] [Related]
32. Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants. D'Angelo V, Ramaglia M, Iannotta A, Crisci S, Indolfi P, Francese M, Affinita MC, Pecoraro G, Napolitano A, Fusco C, Oreste M, Indolfi C, Casale F. Cancer Chemother Pharmacol; 2011 Nov 23; 68(5):1339-46. PubMed ID: 21590445 [Abstract] [Full Text] [Related]
39. An importance of identification of double variant methylenetetrahydrofolate reductase gene C677T and A1298C in cis configuration for pharmacogenetic studies. Palmirotta R, Leone B, De Marchis ML, Ludovici G, Savonarola A, Ferroni P, Rundek T, Roselli M, Della-Morte D, Guadagni F. Blood Coagul Fibrinolysis; 2013 Oct 23; 24(7):784-6. PubMed ID: 24064904 [No Abstract] [Full Text] [Related]
40. Association between the methylenetetrahydrofolate reductase polymorphisms and risk of acute lymphoblastic leukemia in Serbian children. Damnjanovic T, Milicevic R, Novkovic T, Jovicic O, Bunjevacki V, Jekic B, Lukovic L, Novakovic I, Redzic D, Milasin J. J Pediatr Hematol Oncol; 2010 May 23; 32(4):e148-50. PubMed ID: 20445408 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]